VOR
Vor Biopharma·NASDAQ
--
--(--)
--
--(--)
5.61 / 10
Netural
Fund flow analysis scores 7.75/10, highlighting robust liquidity with positive Medium-scale inflows despite negative trends in other buckets. Analyst sentiment is overwhelmingly bullish with a 100% Strong Buy rating from Citigroup, yet the sparse coverage tempers conviction. Together, strong money flow and bullish analyst view provide a supportive backdrop, but the neutral technical and weak fundamental signals warrant caution.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-09
InstitutionCitigroup
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for VOR?
- VOR holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.61/10 (Netural).
